Turnover: 1 million EUR (2022)

Country: France

Genomic Vision is listed on the Euronext regulated market in Paris under the symbol GV.

It specializes in advances in precision genomics to accelerate the identification and bio-production of advanced cell and gene therapies.

In partnership with its customers and partners, the company provides high-quality genomic solutions to improve the quality and production standards of large-scale gene therapies.

Studies mentioning this company

The bioanalysis market - France

Other companies mentioned:

  • Eurofins
  • Carso groupe
  • Mérieux NutriSciences
  • SGS
  • Intertek
  • Bureau Veritas BV
  • Phytocontrol
  • Qualtech (IFBM Groupe)
  • Valbiotis
  • Abbott Groupe
  • Agilent Technologies
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Genomic Vision
  • LFB Groupe
  • Novacyt
  • Qiagen
  • Randox Laboratories
  • Roche Diagnostics France (Roche Group)
  • Thermo Fisher Diagnostics

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.